Last updated: 2026-09-16 09:45:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Solventum Corporation (SOLV) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $90.09, with a market capitalisation of $15.29B and a P/E ratio of 10.69. Over the past 52 weeks, its price has ranged from $62.38 to $94.16. This page covers its latest market performance, valuation, price trends and company information.
$15.29B | |
$90.09 | |
$94.16 | |
$47.16 | |
$90.06 | |
1.00 | |
1.16M | |
10.69 | |
$94.16 | |
$62.38 | |
-- | |
-- |
Solventum Corporation (SOLV) is trading at $90.09 in pre-market trading as of 2026-09-16 08:37:00, up 0.03% ($0.02) from the previous close of $90.06
Pre-market trading shows how investors are pricing SOLV before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Solventum Corporation (SOLV) moved from $91.69 to $90.09, representing a decline of 1.75% ($1.61).
The stock traded between $86.65 and $92.28 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 835.96 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 87.2%
SOLV is currently trading at $90.09, placing it 87.2% of the way from its 52-week low of $62.38 to its 52-week high of $94.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 20000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Solventum Corporation (SOLV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.